SNY - Sanofi's business EPS rose 22% as Dupixent sales grew 34.8%
So what
Dupixent sales jumped 34.8% to €5.69B, while vaccines slipped 6.6% and flu and COVID shots fell 18.8%.
Full-size download: part of Free Access (free). The sheet above stays free to view and share.
Free Access
One free signup opens full-size downloads of every sheet and the pre-earnings pack for each earnings week. No newsletter schedule to sign up for.
Free Access is on: full-size downloads and the pre-earnings pack are open.